The U.S. endoscopy devices market size was exhibited at USD 21.75 billion in 2023 and is projected to hit around USD 41.21 billion by 2033, growing at a CAGR of 6.6% during the forecast period 2024 to 2033.
| Report Coverage | Details |
| Market Size in 2024 | USD 23.19 Billion |
| Market Size by 2033 | USD 41.21 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 6.6% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Product, End-use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Country scope | U.S. |
| Key Companies Profiled | Johnson & Johnson (Ethicon Endo-Surgery, Inc.); Stryker Corporation; Boston Scientific Corporation; CONMED; Medtronic PLC; Fujifilm Holdings Corporation; Olympus Corporation; KARL STORZ SE & Co. KG; Richard Wolf GmbH; Cook Medical |
The increasing number of healthcare centers, such as hospitals, oncology specialty clinics, and cancer centers, contributed to the growing demand for endoscopy devices in the U.S. The rising prevalence of cancer and cancer-related mortality drives the need for endoscopic procedures with enhanced visualization. For instance, according to the American Cancer Society, in the U.S., 1,958,310 new cancer cases and 609,820 cancer deaths are anticipated to occur in 2023.
Technological advancements in minimally invasive surgeries have driven the demand for endoscopy procedures, with capsule endoscopes and robot-assisted endoscopy significantly increasing the need for minimally invasive endoscopic surgeries. Continuous growth in the U.S. market is fueled by advancements in minimally invasive surgeries and the introduction of new products. For instance, in October 2023, Olympus Corporation, a MedTech company, launched its next-generation EVIS X1 endoscopy system to visualize the GI tract.
Furthermore, the emergence of endoscopic bariatric surgeries, such as endoscopic sleeve gastroplasty, has contributed to market growth. This non-surgical procedure, which uses sutures to restructure the stomach and reduce its size by 70.0%, offers promising weight loss results. The minimally invasive nature and affordable pre- and post-procedure costs of endoscopy devices in the country are major factors anticipated to boost the market growth. For instance, according to an article published by Surgery for Obesity and Related Diseases in February 2024, a total number of 280,000 metabolic and bariatric surgeries were performed in 2022.
Moreover, a growing number of product approvals or clearance and innovations in imaging technology are facilitating the trend of new product launches, enhancing the precision & effectiveness of diagnostic and therapeutic procedures. For instance, in August 2021, Boston Scientific Corporation received 510(k) clearance for its EXALT Model B Bronchoscope from the U.S. FDA. This single-use bronchoscope is designed for bedside procedures in Operating Rooms (OR) and Intensive Care Units (ICU), addressing the need for safer alternatives to reusable devices.
Recent technological advancements in endoscopy have increased their demand in hospitals, diagnostic centers, and clinics, driving the disposable endoscopes’ demand. The applications of disposable endoscopy are widening rapidly. Various types of disposable endoscopes are now available and used in numerous specialties, including ENT, laparoscopy, gynecology, arthroscopy, gastroenterology, urology, and proctoscopy. As the market progresses, endoscopic systems are expected to become more integrated and efficient, providing better diagnostic and therapeutic capabilities. Customized solutions combining standard and private-label products would allow manufacturers to rapidly respond to market needs and develop advanced endoscopic technologies.
The endoscopes segment dominated the market in 2023 with revenue share of 37.0% and is expected to witness the fastest CAGR growth from 2024 to 2033. An advanced healthcare infrastructure, high investments by market players and hospitals promoting the use of novel endoscopy equipment, and favorable reimbursement policies are among the factors expected to drive market growth in the U.S. For instance, in June 2021, EvoEndo raised USD 10.1 million to promote using unsedated transnasal endoscopy for patients and physicians.
The increasing preference for minimally invasive surgeries, which offer faster recovery, enhanced precision and accuracy, and reduced post-surgery infections and complications, and the growing preference by physicians to use technologically advanced endoscopy devices equipped with light sources and HD cameras to help them analyze internal organs of interest fuels the market. Moreover, the rising demand for disposable endoscopes and growing investments by several U.S. companies to develop advanced endoscopes are contributing to market growth.
The outpatient facilities segment held the largest revenue share 55.0% in 2023 and is anticipated to grow at the fastest CAGR of 7.1% from 2024 to 2033. The growing number of outpatient care centers in the U.S. boosts the market growth. These outpatient centers offer effective diagnostic and therapeutic options. The rising demand for endoscopes in these settings is increasing due to their multiple benefits. A key benefit in these outpatient environments is the cost-efficiency. For instance, according to the County Business Patterns program in the U.S., there are 54,642 outpatient care centers in 2021.
The hospital's segment in the market held a significant revenue share in 2023. Favorable reimbursement policies for patients visiting hospitals compared to those opting for treatment at ambulatory centers and a significant presence of hospitals and primary care centers in developed and developing economies contribute to the high demand for endoscopes. The increasing preference for minimally invasive surgeries has increased the demand for endoscopy devices in hospitals.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. endoscopy devices market
Product
End-use
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End Use outlook
2.3. Competitive Insights
Chapter 3. U.S. Endoscopy Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Orthopedic digit implants: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Regulatory Framework
3.5. Case Study Analysis
Chapter 4. U.S. Endoscopy Devices Market Segment Analysis, By Product, 2021 - 2033
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. U.S. Endoscopy Devices market, by product, 2021 to 2033
4.5. Endoscopes
4.5.1. Endoscopes market estimates and forecasts, 2021 to 2033
4.5.2. Rigid Endoscopes
4.5.2.1. Rigid Endoscopes market estimates and forecasts, 2021 to 2033
4.5.2.2. Laparoscopes
4.5.2.2.1. Laparoscopes market estimates and forecasts, 2021 to 2033
4.5.2.3. Arthroscopes
4.5.2.3.1. Arthroscopes market estimates and forecasts, 2021 to 2033
4.5.2.4. Ureteroscopes
4.5.2.4.1. Ureteroscopes market estimates and forecasts, 2021 to 2033
4.5.2.5. Cystoscopes
4.5.2.5.1. Cystoscopes market estimates and forecasts, 2021 to 2033
4.5.2.6. Gynecology endoscopes
4.5.2.6.1. Gynecology endoscopes market estimates and forecasts, 2021 to 2033
4.5.2.7. Neuroendoscopes
4.5.2.7.1. Neuroendoscopes market estimates and forecasts, 2021 to 2033
4.5.2.8. Bronchoscopes
4.5.2.8.1. Bronchoscopes market estimates and forecasts, 2021 to 2033
4.5.2.9. Hysteroscopes
4.5.2.9.1. Hysteroscopes market estimates and forecasts, 2021 to 2033
4.5.2.10. Laryngoscopes
4.5.2.10.1. Laryngoscopes market estimates and forecasts, 2021 to 2033
4.5.2.11. Sinuscopes
4.5.2.11.1. Sinuscopes market estimates and forecasts, 2021 to 2033
4.5.2.12. Otoscopes
4.5.2.12.1. Otoscopes market estimates and forecasts, 2021 to 2033
4.5.2.13. Sigmoidoscopes
4.5.2.13.1. Sigmoidoscopes market estimates and forecasts, 2021 to 2033
4.5.2.14. Pharyngoscopes
4.5.2.14.1. Pharyngoscopes market estimates and forecasts, 2021 to 2033
4.5.2.15. Duodenoscope
4.5.2.15.1. Duodenoscope market estimates and forecasts, 2021 to 2033
4.5.2.16. Nasopharyngoscopes
4.5.2.16.1. Nasopharyngoscopes market estimates and forecasts, 2021 to 2033
4.5.2.17. Rhinoscopes
4.5.2.17.1. Rhinoscopes market estimates and forecasts, 2021 to 2033
4.5.2.18. Laparoscopes
4.5.2.18.1. Laparoscopes market estimates and forecasts, 2021 to 2033
4.5.3. Flexible Endoscopes
4.5.3.1. Flexible Endoscopes market estimates and forecasts, 2021 to 2033
4.5.3.2. Laparoscopes
4.5.3.2.1. Laparoscopes market estimates and forecasts, 2021 to 2033
4.5.3.3. Arthroscopes
4.5.3.3.1. Arthroscopes market estimates and forecasts, 2021 to 2033
4.5.3.4. Ureteroscopes
4.5.3.4.1. Ureteroscopes market estimates and forecasts, 2021 to 2033
4.5.3.5. Cystoscopes
4.5.3.5.1. Cystoscopes market estimates and forecasts, 2021 to 2033
4.5.3.6. Gynecology endoscopes
4.5.3.6.1. Gynecology endoscopes market estimates and forecasts, 2021 to 2033
4.5.3.7. Neuroendoscopes
4.5.3.7.1. Neuroendoscopes market estimates and forecasts, 2021 to 2033
4.5.3.8. Bronchoscopes
4.5.3.8.1. Bronchoscopes market estimates and forecasts, 2021 to 2033
4.5.3.9. Hysteroscopes
4.5.3.9.1. Hysteroscopes market estimates and forecasts, 2021 to 2033
4.5.3.10. Laryngoscopes
4.5.3.10.1. Laryngoscopes market estimates and forecasts, 2021 to 2033
4.5.3.11. Sinuscopes
4.5.3.11.1. Sinuscopes market estimates and forecasts, 2021 to 2033
4.5.3.12. Otoscopes
4.5.3.12.1. Otoscopes market estimates and forecasts, 2021 to 2033
4.5.3.13. Sigmoidoscopes
4.5.3.13.1. Sigmoidoscopes market estimates and forecasts, 2021 to 2033
4.5.3.14. Pharyngoscopes
4.5.3.14.1. Pharyngoscopes market estimates and forecasts, 2021 to 2033
4.5.3.15. Duodenoscope
4.5.3.15.1. Duodenoscope market estimates and forecasts, 2021 to 2033
4.5.3.16. Nasopharyngoscopes
4.5.3.16.1. Nasopharyngoscopes market estimates and forecasts, 2021 to 2033
4.5.3.17. Rhinoscopes
4.5.3.17.1. Rhinoscopes market estimates and forecasts, 2021 to 2033
4.5.3.18. Colonoscopes
4.5.3.18.1. Colonoscopes market estimates and forecasts, 2021 to 2033
4.5.4. Disposable Endoscopes
4.5.4.1. Disposable Endoscopes market estimates and forecasts, 2021 to 2033
4.5.4.2. Laparoscopes
4.5.4.2.1. Laparoscopes market estimates and forecasts, 2021 to 2033
4.5.4.3. Arthroscopes
4.5.4.3.1. Arthroscopes market estimates and forecasts, 2021 to 2033
4.5.4.4. Ureteroscopes
4.5.4.4.1. Ureteroscopes market estimates and forecasts, 2021 to 2033
4.5.4.5. Cystoscopes
4.5.4.5.1. Cystoscopes market estimates and forecasts, 2021 to 2033
4.5.4.6. Gynecology endoscopes
4.5.4.6.1. Gynecology endoscopes market estimates and forecasts, 2021 to 2033
4.5.4.7. Neuroendoscopes
4.5.4.7.1. Neuroendoscopes market estimates and forecasts, 2021 to 2033
4.5.4.8. Bronchoscopes
4.5.4.8.1. Bronchoscopes market estimates and forecasts, 2021 to 2033
4.5.4.9. Hysteroscopes
4.5.4.9.1. Hysteroscopes market estimates and forecasts, 2021 to 2033
4.5.4.10. Laryngoscopes
4.5.4.10.1. Laryngoscopes market estimates and forecasts, 2021 to 2033
4.5.4.11. Sinuscopes
4.5.4.11.1. Sinuscopes market estimates and forecasts, 2021 to 2033
4.5.4.12. Otoscopes
4.5.4.12.1. Otoscopes market estimates and forecasts, 2021 to 2033
4.5.4.13. Sigmoidoscopes
4.5.4.13.1. Sigmoidoscopes market estimates and forecasts, 2021 to 2033
4.5.4.14. Pharyngoscopes
4.5.4.14.1. Pharyngoscopes market estimates and forecasts, 2021 to 2033
4.5.4.15. Duodenoscope
4.5.4.15.1. Duodenoscope market estimates and forecasts, 2021 to 2033
4.5.4.16. Nasopharyngoscopes
4.5.4.16.1. Nasopharyngoscopes market estimates and forecasts, 2021 to 2033
4.5.4.17. Rhinoscopes
4.5.4.17.1. Rhinoscopes market estimates and forecasts, 2021 to 2033
4.5.4.18. Colonoscopes
4.5.4.18.1. Colonoscopes market estimates and forecasts, 2021 to 2033
4.5.5. Robot Assisted Endoscope
4.5.5.1. Robot Assisted Endoscopes market estimates and forecasts, 2021 to 2033
4.5.6. Capsule Endoscopes
4.5.6.1. Capsule Endoscopes market estimates and forecasts, 2021 to 2033
4.6. Endoscopy Visualization Systems
4.6.1. Endoscopy Visualization Systems market estimates and forecasts, 2021 to 2033
4.6.2. Standard Definition (SD) Visualization Systems
4.6.2.1. Standard Definition (SD) Visualization Systems market estimates and forecasts, 2021 to 2033
4.6.2.2. 2D Systems
4.6.2.2.1. 2D Systems market estimates and forecasts, 2021 to 2033
4.6.2.3. 3D Systems
4.6.2.3.1. 3D Systems market estimates and forecasts, 2021 to 2033
4.6.3. High Definition (SD) Visualization Systems
4.6.3.1. High Definition (SD) Visualization Systems market estimates and forecasts, 2021 to 2033
4.6.3.2. 2D Systems
4.6.3.2.1. 2D Systems market estimates and forecasts, 2021 to 2033
4.6.3.3. 3D Systems
4.6.3.3.1. 3D Systems market estimates and forecasts, 2021 to 2033
4.7. Endoscopy Visualization Components
4.7.1. Endoscopy Visualization Components market estimates and forecasts, 2021 to 2033
4.7.2. Camera Heads
4.7.2.1. Camera Heads market estimates and forecasts, 2021 to 2033
4.7.3. Insufflators
4.7.3.1. Insufflators market estimates and forecasts, 2021 to 2033
4.7.4. Light Sources
4.7.4.1. Light Sources market estimates and forecasts, 2021 to 2033
4.7.5. High-Definition Monitors
4.7.5.1. High-Definition Monitors market estimates and forecasts, 2021 to 2033
4.7.6. Suction Pumps
4.7.6.1. Suction Pumps market estimates and forecasts, 2021 to 2033
4.7.7. Video Processors
4.7.7.1. Video Processors market estimates and forecasts, 2021 to 2033
4.8. Operative Devices
4.8.1. Operative Devices market estimates and forecasts, 2021 to 2033
4.8.2. Energy Systems
4.8.2.1. Energy Systems market estimates and forecasts, 2021 to 2033
4.8.3. Access Devices
4.8.3.1. Access Devices market estimates and forecasts, 2021 to 2033
4.8.4. Suction & Irrigation Systems
4.8.4.1. Suction & Irrigation Systems market estimates and forecasts, 2021 to 2033
4.8.5. Hand Instruments
4.8.5.1. Hand Instruments market estimates and forecasts, 2021 to 2033
4.8.6. Snares
4.8.6.1. Snares market estimates and forecasts, 2021 to 2033
Chapter 5. U.S. Endoscopy Devices Market Segment Analysis, By End-use, 2021 - 2033
5.1. Definition and Scope
5.2. End-use Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. U.S. Endoscopy Devices Market, by end-use, 2021 to 2033
5.5. Hospitals
5.5.1. Hospitals market estimates and forecasts, 2021 to 2033
5.6. Outpatient facilities
5.6.1. Outpatient facilities market estimates and forecasts, 2021 to 2033
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. Johnson & Johnson (Ethicon Endo-Surgery, Inc.)
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. Stryker Corporation
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Boston Scientific Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. CONMED Corporation
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Medtronic
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Fujifilm Holdings Corporation
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Olympus Corporation (Olympus)
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. KARL STORZ SE & Co. KG
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Richard Wolf GmbH
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Cook Medical
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers